What does a folate level greater than 23.7 ng/mL signify?

High Folate Level (>23.7 ng/mL): Clinical Significance

A folate level greater than 23.7 ng/mL indicates supraphysiologic folate status, most commonly resulting from folic acid supplementation or fortified food consumption, and while generally considered safe in reproductive-age women, warrants evaluation for potential risks in specific populations.

What This Level Represents

A serum folate >23.7 ng/mL places the patient well above standard reference ranges and typically reflects:

• Active supplementation: In 64% of patients with serum folate >25.7 ng/mL, the sample was collected after folic acid supplementation 1
• Adequate to supraphysiologic status: This level exceeds the proposed optimal threshold of ≥13.0 ng/mL for neural tube defect prevention 2
• Post-fortification era levels: Consistent with populations exposed to mandatory food fortification plus supplementation

Clinical Context Matters

In Women of Reproductive Age

This level is generally appropriate and safe when:

• The patient is taking recommended folic acid supplementation (400-800 μg daily) 3
• Planning pregnancy or could become pregnant
• The substantial net benefit for neural tube defect prevention outweighs theoretical concerns 4

Potential Concerns to Evaluate

Check vitamin B12 status immediately - this is the most critical action:

• High folate with low vitamin B12 (<148 pmol/L) creates specific risks 5:
  • Increased insulin resistance in offspring when maternal high folate combines with low B12
  • Anemia and cognitive impairment in elderly patients
  • The masking concern is primarily relevant for patients >65 years 5

Age-related considerations:

• Multivariate analysis shows odds of elevated serum folate increase with age in both men (P<0.001) and women (P=0.01) 6
• White patients and supplement users are significantly more likely to have elevated concentrations 6

Theoretical associations (evidence remains inconclusive) 5:

• Increased lung cancer risk
• Reduced natural killer cell cytotoxicity
• Possible increased cancer risk (no clear confirmatory evidence)
• Slightly increased wheeze and respiratory infections in offspring

Recommended Clinical Actions

1. Obtain vitamin B12 level - this is non-negotiable

   • If B12 <148 pmol/L (deficient) or <221 pmol/L (insufficient), address B12 deficiency
   • Consider methylmalonic acid if B12 borderline

2. Review medication/supplement list:

   • Document all folic acid sources (supplements, prenatal vitamins, fortified foods)
   • Typical supplementation (400-800 μg daily) commonly produces these levels

3. Age-specific assessment:

   • If patient >65 years: More vigilant B12 monitoring due to masking risk
   • If reproductive age: Generally reassuring if taking recommended supplementation

4. Adjust supplementation only if:

   • Patient not planning pregnancy AND
   • Taking excessive doses (>1000 μg daily without indication) AND
   • Concerns about chronic supraphysiologic exposure

Key Clinical Pitfalls

• Do not stop supplementation in women of reproductive age without careful consideration - the neural tube defect prevention benefit is substantial and well-established 4, 5, 3
• Do not ignore B12 status - the combination of high folate with low B12 creates specific metabolic risks that isolated high folate does not 5, 7
• Do not assume toxicity - there is high certainty that folic acid supplementation at recommended doses has substantial net benefit with inadequate evidence for harm 3

Bottom Line

A folate level >23.7 ng/mL is typically benign and expected with standard supplementation, but requires vitamin B12 assessment to exclude the high folate/low B12 combination that poses actual clinical risks. The level itself does not warrant intervention in most patients, particularly women of reproductive age taking recommended supplementation.